RT @ToshifumiYokota: Rohini's new review article just published, focusing on the contribution of Japanese patients and researchers in its d…
RT @RK_Maruyama: 日本新薬さんのDMD治療のためのアンチセンス核酸医薬、ビルテプソについてのレビューが、うちのラボから出ました。
日本新薬さんのDMD治療のためのアンチセンス核酸医薬、ビルテプソについてのレビューが、うちのラボから出ました。
RT @ToshifumiYokota: Rohini's new review article just published, focusing on the contribution of Japanese patients and researchers in its d…
RT @ToshifumiYokota: Rohini's new review article just published, focusing on the contribution of Japanese patients and researchers in its d…
Rohini's new review article just published, focusing on the contribution of Japanese patients and researchers in its development: Pharmacological Profile of Viltolarsen for the Treatment of #DMD: A Japanese Experience @DovePress https://t.co/Mjq6eAXg5Z htt
RT @jonmoulton: Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience. https://t.c…
Pharmacological Profile of Viltolarsen for the Treatment of Duchenne Muscular Dystrophy: A Japanese Experience. https://t.co/JaTDUaaxUR #Morpholino